Patent · US Active

Single-chain TL1A receptor agonist proteins

US10683338B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

APOGENIX AG · DE

Inventors

Christian Gieffers · Dossenheim, DE
Oliver Hill · Neckarsteinach, DE
Meinolf Thiemann · Schriesheim, DE
Tim SCHNYDER · Igersheim, DE

Key dates

Filing date	Apr 20, 2018
Grant date	Jun 16, 2020
Priority date	—
Expiry date	Apr 20, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are specific TL1A receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a TL1A-associated disease or disorder. The TL1A receptor agonist proteins provided herein comprise three soluble TL1A domains and an Fc fragment. The TL1A receptor agonist proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.